Cardinal Health, Inc. (NYSE:CAH - Free Report) - Stock analysts at Zacks Research lifted their Q1 2026 EPS estimates for Cardinal Health in a report released on Wednesday, April 2nd. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $2.04 for the quarter, up from their previous estimate of $2.01. The consensus estimate for Cardinal Health's current full-year earnings is $7.95 per share. Zacks Research also issued estimates for Cardinal Health's Q2 2026 earnings at $1.96 EPS, Q3 2026 earnings at $2.55 EPS, FY2026 earnings at $8.90 EPS, Q1 2027 earnings at $2.16 EPS and FY2027 earnings at $9.39 EPS.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%.
Several other equities analysts also recently commented on the stock. Morgan Stanley upped their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a report on Friday, January 31st. JPMorgan Chase & Co. increased their target price on Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 4th. Mizuho boosted their target price on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research note on Monday, March 31st. Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price on the stock in a research report on Tuesday, January 7th. Finally, Argus set a $148.00 price target on Cardinal Health in a research note on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of "Moderate Buy" and a consensus price target of $140.14.
Get Our Latest Stock Analysis on Cardinal Health
Cardinal Health Trading Up 3.3 %
NYSE:CAH traded up $4.16 during midday trading on Friday, hitting $129.16. 1,255,145 shares of the company traded hands, compared to its average volume of 2,154,046. The firm has a market capitalization of $31.20 billion, a P/E ratio of 24.09, a P/E/G ratio of 1.49 and a beta of 0.61. The firm's fifty day moving average is $128.94 and its 200-day moving average is $121.91. Cardinal Health has a 12-month low of $93.17 and a 12-month high of $139.50.
Cardinal Health Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.57%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.
Institutional Trading of Cardinal Health
A number of hedge funds and other institutional investors have recently modified their holdings of CAH. Czech National Bank increased its position in shares of Cardinal Health by 5.7% during the first quarter. Czech National Bank now owns 55,484 shares of the company's stock valued at $7,644,000 after acquiring an additional 3,011 shares during the last quarter. Rhumbline Advisers grew its stake in shares of Cardinal Health by 5.6% in the first quarter. Rhumbline Advisers now owns 661,367 shares of the company's stock worth $91,116,000 after acquiring an additional 35,312 shares in the last quarter. Fifth Third Wealth Advisors LLC increased its position in shares of Cardinal Health by 8.0% during the first quarter. Fifth Third Wealth Advisors LLC now owns 4,384 shares of the company's stock worth $604,000 after acquiring an additional 326 shares during the period. Welch Group LLC purchased a new position in shares of Cardinal Health in the 1st quarter valued at about $208,000. Finally, Parallel Advisors LLC grew its holdings in Cardinal Health by 9.0% during the 1st quarter. Parallel Advisors LLC now owns 2,511 shares of the company's stock worth $346,000 after acquiring an additional 208 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.
Cardinal Health Company Profile
(
Get Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
